Investor information

Welcome to the Investor Relations section of the Verona Pharma website

This area is dedicated to keeping shareholders and potential investors up to date with our news, share price, and other relevant information.

We are committed to delivering our strategy and creating both near-and long-term value to our shareholders.

AIM

NASDAQ

Latest press releases

  • RNS Number : 4776G Verona Pharma PLC 30 May 2017     TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES i     1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: ii Verona Pharma plc    2 Reason for the
  • RNS Number : 4777G Verona Pharma PLC 30 May 2017       TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES i     1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: ii Verona Pharma plc    2 Reason for the

IR contacts

Investor relations contact
E: info@veronapharma.com
T: +44 (0)203 283 4200

Nominated adviser and broker
N+1 Singer
One Bartholemew Lane
London EC2N 2AX

T: +44 (0)203 283 4200

U.S. Investors
Stephanie Carrington
ICR, Inc.
685 Third Avenue. 2nd Floor
New York, NY 10017

T: 646-277-1282
E: Stephanie.carrington@icrinc.com